Nasonex and Haemorrhagic transformation stroke - from FDA reports


Summary

Haemorrhagic transformation stroke is found among people who take Nasonex, especially for people who are female, 20-29 old , have been taking the drug for 2 - 5 years, also take medication Loratadine, and have Birth control. This review analyzes which people have Haemorrhagic transformation stroke with Nasonex. It is created by eHealthMe based on reports of 19,320 people who have side effects when taking Nasonex from FDA , and is updated regularly.

What to expect?

If you take Nasonex and have Haemorrhagic transformation stroke, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Nasonex and have Haemorrhagic transformation stroke

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 20, 2017

19,320 people reported to have side effects when taking Nasonex.
Among them, 8 people (0.04%) have Haemorrhagic transformation stroke


Number of reports submitted per year:

Could Nasonex cause Haemorrhagic transformation stroke?

Time on Nasonex when people have Haemorrhagic transformation stroke *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haemorrhagic transformation stroke when taking Nasonex *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Haemorrhagic transformation stroke when taking Nasonex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 87.5 %
  • 30-39: 0.0 %
  • 40-49: 12.5 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Birth Control (6 people, 75.00%)
  • Dizziness (3 people, 37.50%)
  • Multiple Sclerosis (1 person, 12.50%)
  • Multiple Myeloma (1 person, 12.50%)
  • Cerebral Thrombosis (1 person, 12.50%)

Top co-used drugs for these people *:

  • Loratadine (8 people, 100.00%)
  • Yasmin (7 people, 87.50%)
  • Rhinocort (7 people, 87.50%)
  • Patanol (7 people, 87.50%)
  • Acetaminophen (7 people, 87.50%)

Top other side effects for these people *:

  • Visual Impairment (8 people, 100.00%)
  • Stress And Anxiety (8 people, 100.00%)
  • Oedema (7 people, 87.50%)
  • Nausea And Vomiting (7 people, 87.50%)
  • Cerebral Venous Thrombosis (7 people, 87.50%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Haemorrhagic transformation stroke when taking Nasonex?

Expand the study to include all drugs with the same ingredients

Haemorrhagic transformation stroke and drugs with ingredients of mometasone furoate monohydrate.

Expand the study to include reports from both FDA and eHealthMe

Haemorrhagic transformation stroke and Nasonex from FDA and eHealthMe reports

Nasonex

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. (latest outcomes from Nasonex 20,382 users)

Haemorrhagic transformation stroke

Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia) has been reported by people with stroke, atrial fibrillation/flutter, ischaemic stroke, thrombosis, high blood pressure (latest reports from 614 Haemorrhagic transformation stroke patients).

Browse all side effects of Nasonex

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Haemorrhagic transformation stroke

Haemorrhagic transformation stroke

Could your condition cause Haemorrhagic transformation stroke

Haemorrhagic transformation stroke

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Nasonex and have Haemorrhagic transformation stroke.

User reviews to the study

More reviews >